Anu V. Chandran
Research Subjects
Anu V. Chandran has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Peter Marples
Diamond Light Source
17 shared publications - Frank von Delft
Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, UK
12 shared publications - Lizbé Koekemoer
Centre for Medicines Discovery University of Oxford Old Road Campus, Roosevelt Drive OX3 7DQ Headington UK
11 shared publications - Mathew Golding
Diamond Light Source, Harwell Science and Innovation Campus
11 shared publications Charlotte Chinn
10 shared publications- Michael Fairhead
ASAP Discovery Consortium ASAP Discovery Discovery University of Oxford ASAP D
10 shared publications
Latest Publications
- Open Access
- 6 August 2026
- Published by Springer Nature
Dengue virus NS5 RdRp protease binding assay for compound screening using grating-coupled interferometry v1
This protocol aims to measure kinetic parameters (ka, kd, and KD) for compounds against Dengue virus (DENV) NS5 RdRp protease using the Creoptix Wave system. Grating-coupled interferometry (GCI) is a label-free technique to measure kinetics and affinity for different targets (proteins, small molecules, fragments, etc.) with enhanced sensitivity. Biotin-tagged DENV NS5 RdRp protease was captured on the streptavidin-coated chip surface. This immobilisation technique provides oriented and active protein immobilisation for binding assays and can be applied to different protein targets. Binding analysis was performed with the Repeated Analyte Pulses of Increasing Duration (RAPID) method, which involves the injection of samples at a single concentration with varied association times. Kinetic parameters were obtained from the Creoptix Wave software (v 4.5.18) and the in-house developed, open-source, Python-based tool 'SensoFit' (xchem/sensofit).
- 6 August 2026
- Published by Springer Nature
Open AccessDengue virus NS5 RdRp protease binding assay for compound screening using grating-coupled interferometry v1
This protocol aims to measure kinetic parameters (ka, kd, and KD) for compounds against Dengue virus (DENV) NS5 RdRp protease using the Creoptix Wave system. Grating-coupled interferometry (GCI) is a label-free technique to measure kinetics and affinity for different targets (proteins, small molecules, fragments, etc.) with enhanced sensitivity. Biotin-tagged DENV NS5 RdRp protease was captured on the streptavidin-coated chip surface. This immobilisation technique provides oriented and active protein immobilisation for binding assays and can be applied to different protein targets. Binding analysis was performed with the Repeated Analyte Pulses of Increasing Duration (RAPID) method, which involves the injection of samples at a single concentration with varied association times. Kinetic parameters were obtained from the Creoptix Wave software (v 4.5.18) and the in-house developed, open-source, Python-based tool 'SensoFit' (xchem/sensofit).
- Open Access
- 6 August 2026
- Published by Springer Nature
Zika virus NS5 RdRp protease binding assay for compound screening using grating-coupled interferometry v1
This protocol aims to measure kinetic parameters (ka, kd, and KD) for compounds against Zika virus (ZIKV) NS5 RdRp protease using the Creoptix Wave system. Grating-coupled interferometry (GCI) is a label-free technique to measure kinetics and affinity for different targets (proteins, small molecules, fragments, etc.) with enhanced sensitivity. Biotin-tagged ZIKV NS5 RdRp protease was captured on the streptavidin-coated chip surface. This immobilisation technique provides oriented and active protein immobilisation for binding assays and can be applied to different protein targets. Binding analysis was performed with the Repeated Analyte Pulses of Increasing Duration (RAPID) method, which involves the injection of samples at a single concentration with varied association times. Kinetic parameters were obtained from the Creoptix Wave software (v 4.5.18) and the in-house developed, open-source, Python-based tool 'SensoFit' (xchem/sensofit).
- 6 August 2026
- Published by Springer Nature
Open AccessZika virus NS5 RdRp protease binding assay for compound screening using grating-coupled interferometry v1
This protocol aims to measure kinetic parameters (ka, kd, and KD) for compounds against Zika virus (ZIKV) NS5 RdRp protease using the Creoptix Wave system. Grating-coupled interferometry (GCI) is a label-free technique to measure kinetics and affinity for different targets (proteins, small molecules, fragments, etc.) with enhanced sensitivity. Biotin-tagged ZIKV NS5 RdRp protease was captured on the streptavidin-coated chip surface. This immobilisation technique provides oriented and active protein immobilisation for binding assays and can be applied to different protein targets. Binding analysis was performed with the Repeated Analyte Pulses of Increasing Duration (RAPID) method, which involves the injection of samples at a single concentration with varied association times. Kinetic parameters were obtained from the Creoptix Wave software (v 4.5.18) and the in-house developed, open-source, Python-based tool 'SensoFit' (xchem/sensofit).
- Open Access
- 24 July 2026
- Published by Springer Nature
Coxsackievirus A16 2A protease binding assay for compound screening using grating-coupled interferometry v2
This protocol aims to measure kinetic parameters (ka, kd, and KD) for compounds against coxsackievirus A16 (CVA16) 2A protease using the Creoptix Wave system. CVA16 2A protease is used as a surrogate for the related enterovirus A71 (EV-A71) 2A protease in the pan-enteroviral drug discovery efforts by our collaborator, the AI-Driven Structure-Enabled Antiviral Platform (ASAP) Discovery Center, and was chosen as the target for OpenBind's first data release package. Grating-coupled interferometry (GCI) is a label-free technique to measure kinetics and affinity for different targets (proteins, small molecules, fragments, etc.) with enhanced sensitivity. Biotin-tagged CVA16 2A protease was captured on the streptavidin-coated chip surface. This immobilisation technique provides oriented and active protein immobilisation for binding assays and can be applied to different protein targets. Binding analysis was performed with the Repeated Analyte Pulses of Increasing Duration (RAPID) method, which involves the injection of samples at a single concentration with varied association times. Kinetic parameters were obtained from the Creoptix Wave software (v 4.5.18) and the in-house developed, open-source, Python-based tool 'SensoFit' (xchem/sensofit).
- 24 July 2026
- Published by Springer Nature
Open AccessCoxsackievirus A16 2A protease binding assay for compound screening using grating-coupled interferometry v2
This protocol aims to measure kinetic parameters (ka, kd, and KD) for compounds against coxsackievirus A16 (CVA16) 2A protease using the Creoptix Wave system. CVA16 2A protease is used as a surrogate for the related enterovirus A71 (EV-A71) 2A protease in the pan-enteroviral drug discovery efforts by our collaborator, the AI-Driven Structure-Enabled Antiviral Platform (ASAP) Discovery Center, and was chosen as the target for OpenBind's first data release package. Grating-coupled interferometry (GCI) is a label-free technique to measure kinetics and affinity for different targets (proteins, small molecules, fragments, etc.) with enhanced sensitivity. Biotin-tagged CVA16 2A protease was captured on the streptavidin-coated chip surface. This immobilisation technique provides oriented and active protein immobilisation for binding assays and can be applied to different protein targets. Binding analysis was performed with the Repeated Analyte Pulses of Increasing Duration (RAPID) method, which involves the injection of samples at a single concentration with varied association times. Kinetic parameters were obtained from the Creoptix Wave software (v 4.5.18) and the in-house developed, open-source, Python-based tool 'SensoFit' (xchem/sensofit).
- Open Access
- 20 July 2026
- Published by Springer Nature
Zika virus NS2B-NS3 protease binding assay for compound screening using grating-coupled interferometry v1
This protocol aims to measure kinetic parameters (ka, kd, and KD) for compounds against Zika virus (ZIKV) NS2B-NS3 protease using the Creoptix Wave system. Grating-coupled interferometry (GCI) is a label-free technique to measure kinetics and affinity for different targets (proteins, small molecules, fragments, etc.) with enhanced sensitivity. Biotin-tagged ZIKV NS2B-NS3 protease was captured on the streptavidin-coated chip surface. This immobilisation technique provides oriented and active protein immobilisation for binding assays and can be applied to different protein targets. Binding analysis was performed with the Repeated Analyte Pulses of Increasing Duration (RAPID) method, which involves the injection of samples at a single concentration with varied association times. Kinetic parameters were obtained from the Creoptix Wave software (v 4.5.18) and the in-house developed, open-source, Python-based tool 'SensoFit' (xchem/sensofit).
- 20 July 2026
- Published by Springer Nature
Open AccessZika virus NS2B-NS3 protease binding assay for compound screening using grating-coupled interferometry v1
This protocol aims to measure kinetic parameters (ka, kd, and KD) for compounds against Zika virus (ZIKV) NS2B-NS3 protease using the Creoptix Wave system. Grating-coupled interferometry (GCI) is a label-free technique to measure kinetics and affinity for different targets (proteins, small molecules, fragments, etc.) with enhanced sensitivity. Biotin-tagged ZIKV NS2B-NS3 protease was captured on the streptavidin-coated chip surface. This immobilisation technique provides oriented and active protein immobilisation for binding assays and can be applied to different protein targets. Binding analysis was performed with the Repeated Analyte Pulses of Increasing Duration (RAPID) method, which involves the injection of samples at a single concentration with varied association times. Kinetic parameters were obtained from the Creoptix Wave software (v 4.5.18) and the in-house developed, open-source, Python-based tool 'SensoFit' (xchem/sensofit).
- Open Access
- 10 June 2026
- Published by Springer Nature
Crystallisation of Zika NS5 RdRp v1
The main aim of this work was to identify small molecules that bind Zika NS5 RdRp (catalytic RNA-dependent RNA polymerase domain) through X-ray fragment-based screening. The Zika NS5 RDRP domain was cloned, expressed, purified, and crystallised. Suitable crystals for fragment screening were produced and optimised allowing an extensive fragment campaign to be performed. A native high-resolution structure was determined at 1.8Å and formed the basis for the fragment campaign. This has been used as the basis for work on the target for OpenBind
- 10 June 2026
- Published by Springer Nature
Open AccessCrystallisation of Zika NS5 RdRp v1
The main aim of this work was to identify small molecules that bind Zika NS5 RdRp (catalytic RNA-dependent RNA polymerase domain) through X-ray fragment-based screening. The Zika NS5 RDRP domain was cloned, expressed, purified, and crystallised. Suitable crystals for fragment screening were produced and optimised allowing an extensive fragment campaign to be performed. A native high-resolution structure was determined at 1.8Å and formed the basis for the fragment campaign. This has been used as the basis for work on the target for OpenBind
- Open Access
- 1 May 2026
- Published by Springer Nature
Assessing protein crystal tolerance of chemistry reagents for HT-crystallographic screening v2
This protocol describes the testing of how protein crystals survive exposure to organic chemistry reagents and solvents, with the purpose of reducing crystal attrition prior to high-throughput crystallographic screening of ligands from crude reaction mixtures containing the reagents. A step-by-step description is included, describing how to complete this process using the XChem laboratory at Diamond Light Source and the Protein Crystallisation Facility at the Research Complex at Harwell. The data analysis cut-offs, rationale, and GitHub repo for the code utilised during analysis are included. This version updates the old spreadsheet-based analysis with a Python program using pandas dataframes, XtalControl. (v.02 at time of writing) https://github.com/xchem/XtalControl
- 1 May 2026
- Published by Springer Nature
Open AccessAssessing protein crystal tolerance of chemistry reagents for HT-crystallographic screening v2
This protocol describes the testing of how protein crystals survive exposure to organic chemistry reagents and solvents, with the purpose of reducing crystal attrition prior to high-throughput crystallographic screening of ligands from crude reaction mixtures containing the reagents. A step-by-step description is included, describing how to complete this process using the XChem laboratory at Diamond Light Source and the Protein Crystallisation Facility at the Research Complex at Harwell. The data analysis cut-offs, rationale, and GitHub repo for the code utilised during analysis are included. This version updates the old spreadsheet-based analysis with a Python program using pandas dataframes, XtalControl. (v.02 at time of writing) https://github.com/xchem/XtalControl
- Open Access
- 14 April 2026
- Published by Springer Nature
Assessing protein crystal tolerance of chemistry reagents for HT-crystallographic screening v2
This protocol describes the testing of how protein crystals survive exposure to organic chemistry reagents and solvents, with the purpose of reducing crystal attrition prior to high-throughput crystallographic screening of ligands from crude reaction mixtures containing the reagents. A step-by-step description is included, describing how to complete this process using the XChem laboratory at Diamond Light Source and the Protein Crystallisation Facility at the Research Complex at Harwell. The data analysis cutoffs, rationale, and the spreadsheet used during analysis are also included within the attachments.
- 14 April 2026
- Published by Springer Nature
Open AccessAssessing protein crystal tolerance of chemistry reagents for HT-crystallographic screening v2
This protocol describes the testing of how protein crystals survive exposure to organic chemistry reagents and solvents, with the purpose of reducing crystal attrition prior to high-throughput crystallographic screening of ligands from crude reaction mixtures containing the reagents. A step-by-step description is included, describing how to complete this process using the XChem laboratory at Diamond Light Source and the Protein Crystallisation Facility at the Research Complex at Harwell. The data analysis cutoffs, rationale, and the spreadsheet used during analysis are also included within the attachments.
- Open Access
- 10 April 2026
- Published by Springer Nature
Crystallisation of coxsackievirus A16 2A protease in space group C2 used for apo, fragment screen and follow-up compounds v1
This protocol was used to grow coxsackievirus A16 (CVA16) 2A protease crystals that were used as a surrogate for enterovirus A71 (EV-A71) 2A protease in high-throughput crystallographic fragment screening and in the crystallographic screening of follow-up compounds against the target. (PDB ID of apo-structure solved using sulfur phasing: pdb_000029jc) Picornaviridae, primarily CVA16 and EV-A71, are the causative agents of paediatric hand-foot-and-mouth disease. These viruses are a target for pandemic preparedness due to the risk of higher-order complications in a large-scale outbreak. The 2A protease of the viruses is responsible for self-cleavage from the polyprotein, allowing for correct folding and assembly of capsid proteins in the final stages of viral replication. Inhibition deranges capsid folding and assembly, preventing formation of mature virions in host cells and making the protease a valuable target for antiviral activity.
- 10 April 2026
- Published by Springer Nature
Open AccessCrystallisation of coxsackievirus A16 2A protease in space group C2 used for apo, fragment screen and follow-up compounds v1
This protocol was used to grow coxsackievirus A16 (CVA16) 2A protease crystals that were used as a surrogate for enterovirus A71 (EV-A71) 2A protease in high-throughput crystallographic fragment screening and in the crystallographic screening of follow-up compounds against the target. (PDB ID of apo-structure solved using sulfur phasing: pdb_000029jc) Picornaviridae, primarily CVA16 and EV-A71, are the causative agents of paediatric hand-foot-and-mouth disease. These viruses are a target for pandemic preparedness due to the risk of higher-order complications in a large-scale outbreak. The 2A protease of the viruses is responsible for self-cleavage from the polyprotein, allowing for correct folding and assembly of capsid proteins in the final stages of viral replication. Inhibition deranges capsid folding and assembly, preventing formation of mature virions in host cells and making the protease a valuable target for antiviral activity.
- Open Access
- 31 March 2026
- Published by Springer Nature
Coxsackievirus A16 2A protease binding assay for compound screening using grating-coupled interferometry v1
This protocol aims to measure kinetic parameters (ka, kd, and KD) for compounds against coxsackievirus A16 (CVA16) 2A protease using the Creoptix Wave system. CVA16 2A protease is used as a surrogate for the related enterovirus A71 (EV-A71) 2A protease in the pan-enteroviral drug discovery efforts by our collaborator, the AI-Driven Structure-Enabled Antiviral Platform (ASAP) Discovery Center, and was chosen as the target for OpenBind's first data release package. Grating-coupled interferometry (GCI) is a label-free technique to measure kinetics and affinity for different targets (proteins, small molecules, fragments, etc.) with enhanced sensitivity. Biotin-tagged CVA16 2A protease was captured on the streptavidin-coated chip surface via biotinylation. This immobilisation technique provides oriented and active protein immobilisation for binding assays and can be applied to different protein targets. Binding analysis was performed with the Repeated Analyte Pulses of Increasing Duration (RAPID) method, which involves the injection of samples at a single concentration with varied association times. Kinetic parameters were obtained from the Creoptix Wave software (v 4.5.18) and the in-house developed, open-source, Python-based tool 'SensoFit' (xchem/sensofit).
- 31 March 2026
- Published by Springer Nature
Open AccessCoxsackievirus A16 2A protease binding assay for compound screening using grating-coupled interferometry v1
This protocol aims to measure kinetic parameters (ka, kd, and KD) for compounds against coxsackievirus A16 (CVA16) 2A protease using the Creoptix Wave system. CVA16 2A protease is used as a surrogate for the related enterovirus A71 (EV-A71) 2A protease in the pan-enteroviral drug discovery efforts by our collaborator, the AI-Driven Structure-Enabled Antiviral Platform (ASAP) Discovery Center, and was chosen as the target for OpenBind's first data release package. Grating-coupled interferometry (GCI) is a label-free technique to measure kinetics and affinity for different targets (proteins, small molecules, fragments, etc.) with enhanced sensitivity. Biotin-tagged CVA16 2A protease was captured on the streptavidin-coated chip surface via biotinylation. This immobilisation technique provides oriented and active protein immobilisation for binding assays and can be applied to different protein targets. Binding analysis was performed with the Repeated Analyte Pulses of Increasing Duration (RAPID) method, which involves the injection of samples at a single concentration with varied association times. Kinetic parameters were obtained from the Creoptix Wave software (v 4.5.18) and the in-house developed, open-source, Python-based tool 'SensoFit' (xchem/sensofit).
- Open Access
- 30 March 2026
- Published by Springer Nature
Assessing protein crystal tolerance of chemistry reagents for HT-crystallographic screening. v1
This protocol describes the testing of how protein crystals survive exposure to organic chemistry reagents and solvents, with the purpose of reducing crystal attrition prior to high-throughput crystallographic screening of ligands from crude reaction mixtures containing the reagents. A step-by-step description is included, describing how to complete this process using the XChem laboratory and Protein Crystallisation Facility at Diamond Light Source. The data analysis cutoffs, rationale, and the spreadsheet used during analysis are also included within the attachments.
- 30 March 2026
- Published by Springer Nature
Open AccessAssessing protein crystal tolerance of chemistry reagents for HT-crystallographic screening. v1
This protocol describes the testing of how protein crystals survive exposure to organic chemistry reagents and solvents, with the purpose of reducing crystal attrition prior to high-throughput crystallographic screening of ligands from crude reaction mixtures containing the reagents. A step-by-step description is included, describing how to complete this process using the XChem laboratory and Protein Crystallisation Facility at Diamond Light Source. The data analysis cutoffs, rationale, and the spreadsheet used during analysis are also included within the attachments.